Advertisement
Convey Health Solutions Holdings, Inc.

Convey Health Solutions Holdings, Inc. Fundamental Analysis

CNVYNYSE
HealthcareMedical - Healthcare Information Services
$10.51
$0.05(0.47%)
U.S. Market is Open · 12:42
Advertisement

Convey Health Solutions Holdings, Inc. Fundamental Analysis

Convey Health Solutions Holdings, Inc. (CNVY) shows weak financial fundamentals with a PE ratio of -70.20, profit margin of -2.96%, and ROE of -1.98%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.19
Current Ratio1.88

Areas of Concern

ROE-1.98%
Operating Margin-8.27%
We analyze CNVY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 31.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
31.1/100

We analyze CNVY's fundamental strength across five key dimensions:

Efficiency Score

Weak

CNVY struggles to generate sufficient returns from assets.

ROA > 10%
-1.20%

Valuation Score

Excellent

CNVY trades at attractive valuation levels.

PE < 25
-70.20
PEG Ratio < 2
0.19

Growth Score

Weak

CNVY faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

CNVY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
1.88

Profitability Score

Weak

CNVY struggles to sustain strong margins.

ROE > 15%
-198.00%
Net Margin ≥ 15%
-2.96%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is CNVY Expensive or Cheap?

P/E Ratio

CNVY trades at -70.20 times earnings. This suggests potential undervaluation.

-70.20

PEG Ratio

When adjusting for growth, CNVY's PEG of 0.19 indicates potential undervaluation.

0.19

Price to Book

The market values Convey Health Solutions Holdings, Inc. at 1.30 times its book value. This may indicate undervaluation.

1.30

EV/EBITDA

Enterprise value stands at -1.72 times EBITDA. This is generally considered low.

-1.72

How Well Does CNVY Make Money?

Net Profit Margin

For every $100 in sales, Convey Health Solutions Holdings, Inc. keeps $-2.96 as profit after all expenses.

-2.96%

Operating Margin

Core operations generate -8.27 in profit for every $100 in revenue, before interest and taxes.

-8.27%

ROE

Management delivers $-1.98 in profit for every $100 of shareholder equity.

-1.98%

ROA

Convey Health Solutions Holdings, Inc. generates $-1.20 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.20%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.22 in free cash annually.

$-0.22

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-70.20

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.19

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.30

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.001

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.88

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.02

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

-0.04

vs 25 benchmark

How CNVY Stacks Against Its Sector Peers

MetricCNVY ValueSector AveragePerformance
P/E Ratio-70.2034.27 Better (Cheaper)
ROE-1.98%377.00% Weak
Net Margin-2.96%-42945.00% (disorted) Weak
Debt/Equity0.000.78 Strong (Low Leverage)
Current Ratio1.885.54 Neutral
ROA-1.20%-162.00% (disorted) Weak

CNVY outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Convey Health Solutions Holdings, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ